MedPage Today -- A program bundling generic forms of a statin and an ACE inhibitor appears to cut rates of myocardial infarction and stroke, researchers found. In a large California healthcare delivery system, the program -- designed to minimize outpatient visits, laboratory tests, and dosage titration -- prevented an estimated 1,271 MIs and strokes in the first year after treatment.
